Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

990 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma.
Porter AB, Giannini C, Kaufmann T, Lucchinetti CF, Wu W, Decker PA, Atkinson JL, O'Neill BP. Porter AB, et al. Among authors: giannini c. Ann Neurol. 2008 May;63(5):662-7. doi: 10.1002/ana.21366. Ann Neurol. 2008. PMID: 18481293 Clinical Trial.
Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks.
Sarkaria JN, Galanis E, Wu W, Dietz AB, Kaufmann TJ, Gustafson MP, Brown PD, Uhm JH, Rao RD, Doyle L, Giannini C, Jaeckle KA, Buckner JC. Sarkaria JN, et al. Among authors: giannini c. Clin Cancer Res. 2010 Nov 15;16(22):5573-80. doi: 10.1158/1078-0432.CCR-10-1453. Epub 2010 Oct 4. Clin Cancer Res. 2010. PMID: 20921209 Free PMC article. Clinical Trial.
Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, Xiao Y, Kollmeyer TM, Rynearson AL, Fink S, Rice T, McCoy LS, Halder C, Kosel ML, Giannini C, Tihan T, O'Neill BP, Lachance DH, Yang P, Wiemels J, Wiencke JK. Jenkins RB, et al. Among authors: giannini c. Cancer Genet. 2011 Jan;204(1):13-8. doi: 10.1016/j.cancergencyto.2010.10.002. Cancer Genet. 2011. PMID: 21356187 Free PMC article.
Gliomatosis cerebri: clinical characteristics, management, and outcomes.
Chen S, Tanaka S, Giannini C, Morris J, Yan ES, Buckner J, Lachance DH, Parney IF. Chen S, et al. Among authors: giannini c. J Neurooncol. 2013 Apr;112(2):267-75. doi: 10.1007/s11060-013-1058-x. Epub 2013 Jan 23. J Neurooncol. 2013. PMID: 23341100 Free PMC article. Clinical Trial.
Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, Kemp BJ, Grams MP, Morris JM, Hoover JM, Hu LS, Sarkaria JN, Brinkmann DH. Pafundi DH, et al. Among authors: giannini c. Neuro Oncol. 2013 Aug;15(8):1058-67. doi: 10.1093/neuonc/not002. Epub 2013 Mar 3. Neuro Oncol. 2013. PMID: 23460322 Free PMC article.
Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial.
Galanis E, Anderson SK, Lafky JM, Uhm JH, Giannini C, Kumar SK, Kimlinger TK, Northfelt DW, Flynn PJ, Jaeckle KA, Kaufmann TJ, Buckner JC. Galanis E, et al. Among authors: giannini c. Clin Cancer Res. 2013 Sep 1;19(17):4816-23. doi: 10.1158/1078-0432.CCR-13-0708. Epub 2013 Jul 5. Clin Cancer Res. 2013. PMID: 23833308 Free PMC article. Clinical Trial.
990 results